Risk factor analysis for linezolid-associated thrombocytopenia in critically ill patients
- 18 December 2019
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 39 (3) , 527-538
Abstract
Linezolid is an antibiotic used against gram-positive bacteria, including methicillin-resistant Staphylococcus aureus. Its primary adverse effect is haematotoxicity. The objective of this study was to analyse the risk factors for onset of thrombocytopenia in critically ill patients treated with linezolid. This was a retrospective, single-centre study of 72 patients. Platelets were measured from D0 to D20 after the start of treatment. The risk factors for thrombocytopenia were identified using a multivariate logistic regression analysis following a Monte Carlo simulation. Following ROC curve analysis, a baseline platelet count lower than 108 × 109/L and a Cmin higher than 4 mg/L, with respective odds ratios of 117 (95% CI [97–206]) and 3 (95% CI [1.5–6.2]) in the simulated population, were identified as risk factors. Among the source population patients combining these 2 factors, a significantly higher number developed thrombocytopenia (66.7% vs. 33.3%, p = 0.0042). A baseline platelet count lower than 108 × 109/L and a Cmin higher than 4 mg/L are risk factors for the onset of thrombocytopenia in critically ill patients treated with linezolid.Keywords
This publication has 26 references indexed in Scilit:
- Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patientsInternational Journal of Antimicrobial Agents, 2014
- Risk factors for linezolid-associated thrombocytopenia in adult patientsInfection, 2014
- Linezolid-induced thrombocytopenia in impaired renal function: is it time for a dose adjustment? A case report and review of literatureEuropean Journal of Clinical Pharmacology, 2013
- High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopeniaJournal of Antimicrobial Chemotherapy, 2013
- Chronic liver disease increases the risk of linezolid-related thrombocytopenia in methicillin-resistant Staphylococcus aureus-infected patients after digestive surgeryJournal of Infection and Chemotherapy, 2011
- Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunctionInternational Journal of Antimicrobial Agents, 2010
- High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiencyInternational Journal of Antimicrobial Agents, 2006
- Multistate Outbreak of Listeriosis Linked to Turkey Deli Meat and Subsequent Changes in US Regulatory PolicyClinical Infectious Diseases, 2006
- Linezolid: low pre-treatment platelet values could increase the risk of thrombocytopeniaJournal of Antimicrobial Chemotherapy, 2005
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976